NCT04738474View on ClinicalTrials.gov

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

July 25, 2024

Study Completion Date

July 25, 2024

Conditions
Congenital Heart Disease
Interventions
BEHAVIORAL

Promoting Resilience in Stress Management (PRISM)

"Develops personal resilience resources through 1:1 sessions with a PRISM coach."

OTHER

Usual Care

No additional study-specific interaction with subjects. Subjects continue to receive usual medical care.

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER